http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01163155-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
filingDate 1988-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a48cb8be90afcd3b9f41ff9c47b2ea2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1279d98782c00b7ed8767a8017b2f8
publicationDate 1989-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H01163155-A
titleOfInvention Optically active 1-biphenylethanol derivative and production thereof
abstract NEW MATERIAL:An optically active 1-biphenylylethanol derivative expressed by formula I (R is H or acetyl; R' is 1W15C alkyl or formula II; A is H, halogen, lower alkyl or lower alkoxyl; x indicates asymmetric carbon atom). n EXAMPLE: Ethyl (+)-4'-(1-hydroxyethyl)-4-biphenylcarboxylate. n USE: Useful as an intermediate for medicines, agricultural chemicals, etc., particularly as an organic electronic material, especially an intermediate for liquid crystal compounds. For example, a novel compound can be converted into a liquid crystal compound which is excellent as a ferroelectric liquid crystal as shown in the reaction formula IV. n PREPARATION: dl-Esters expressed by formula III are asymmetrically hydrolyzed with an esterase having the ability to hydrolyze either of enantiomers thereof to afford the aimed compound expressed by formula I. n COPYRIGHT: (C)1989,JPO&Japio
priorityDate 1987-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414967527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14425758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420158020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455858454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228738069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235853410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234745826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68852832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411228274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13924054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14617983

Total number of triples: 27.